Prion protein: Orchestrating neurotrophic activities

Current Issues in Molecular Biology

Volumn 12, Issue 2, 2010, Pages 63-86

  Martins, Vilma R ^a   Beraldo, Flavio H ^a   Hajj, Glaucia N ^a   Lopes, Marilene H ^a   Lee, Kil Sun ^b   Prado, Marco A ^c,d   Linden, Rafael ^e  

^a HOSPITAL ALEMÃO OSWALDO CRUZ   (Brazil)

^b Associacao Fundo de Incentivo a Psicofarmacologia   (Brazil)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^e FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; ION CHANNEL; MEMBRANE PROTEIN; NEUROTROPHIC FACTOR; PRION PROTEIN; SCLEROPROTEIN; PRION;

ASTROCYTE; BRAIN SPONGIOSIS; CELL DIFFERENTIATION; CELL SURFACE; CELL SURVIVAL; DEGENERATIVE DISEASE; HUMAN; MUTATION; NERVE CELL; NEUROTROPISM; NONHUMAN; PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; ANIMAL; BIOLOGICAL MODEL; GENETICS; METABOLISM; MOUSE; PRION; PRION DISEASES;

MUS MUSCULUS;

ANIMALS; HUMANS; MICE; MODELS, GENETIC; PRION DISEASES; PRIONS; PRPC PROTEINS; PRPSC PROTEINS;

EID: 74749098705     PISSN: 14673037     EISSN: None     Source Type: Journal    
DOI: 10.21775/9781912530076.02     Document Type: Review

References (236)

1. Alfa CM, Sunyach C, Slack BE, Fisher A, Vincent B, and Checler F (2007) M1 and M3 muscarinic receptors control physiological processing of cellular prion by modulating ADAM17 phosphorylation and activity. J Neurosci, 27, 4083-4092.
2. Americo TA, Chiarini LB, and Linden R (2007) Signaling induced by hop/STI-1 depends on endocytosis. Biochem Biophys Res Commun, 358, 620-625.
3. Azmitia EC (2002) Cajal's hypotheses on neurobiones and neurotropic factor match properties of microtubules and S-100 beta. Prog Brain Res, 136, 87-100.
4. Azzalin A, Ferrara V, Arias A, Cerri S, Avella D, Pisu MB, Nano R, Bernocchi G, Ferretti L, and Comincini S (2006) Interaction between the cellular prion (PrPC) and the 2P domain K+ channel TREK-1 protein. Biochem Biophys Res Commun, 346, 108-115.
5. Bainbridge J and Walker KB (2005) The normal cellular form of prion protein modulates T cell responses. Immunol Lett, 96, 147-150.
6. Baumann F, Tolnay M, Brabeck C, Pahnke J, Kloz U, Niemann HH, Heikenwalder M, Rulicke T, Burkle A, and Aguzzi A (2007) Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J, 26, 538-547.
7. Beringue V, Mallinson G, Kaisar M, Tayebi M, Sattar Z, Jackson G, Anstee D, Collinge J, and Hawke S (2003) Regional heterogeneity of cellular prion protein isoforms in the mouse brain. Brain, 126, 2065-2073.
8. Bezman N and Koretzky GA (2007) Compartmentalization of ITAM and integrin signaling by adapter molecules. Immunol Rev, 218, 9-28.
9. Bhattacharyya RP, Remenyi A, Yeh BJ, and Lim WA (2006) Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits. Annu Rev Biochem, 75, 655-680.
10. Blochl A and Blochl R (2007) A cell-biological model of p75NTR signaling. J Neurochem, 102, 289-305.
11. Borchelt DR, Rogers M, Stahl N, Telling G, and Prusiner SB (1993) Release of the cellular prion protein from cultured cells after loss of its glycoinositol phospholipid anchor. Glycobiology, 3, 319-329.
12. Brini M, Miuzzo M, Pierobon N, Negro A, and Sorgato MC (2005) The prion protein and its paralogue Doppel affect calcium signaling in Chinese hamster ovary cells. Mol Biol Cell, 16, 2799-2808.
13. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M, and Weissmann C (1992) Normal development and behaviour of mice lacking the neuronal cell- surface PrP protein. Nature, 356, 577-582.
14. Cabral AL, Lee KS, and Martins VR (2002) Regulation of the cellular prion protein gene expression depends on chromatin conformation. J Biol Chem, 277, 5675-5682.
15. Caetano FA, Lopes MH, Hajj GN, Machado CF, Pinto AC, Magalhaes AC, Vieira MP, Americo TA, Massensini AR, Priola SA, Vorberg I, Gomez MV, Linden R, Prado VF, Martins VR, and Prado MA (2008) Endocytosis of prion protein is required for ERK1/2 signaling induced by stress-inducible protein 1. J Neurosci, 28, 6691-6702.
16. Calixto JB, Medeiros R, Fernandes ES, Ferreira J, Cabrini DA, and Campos MM (2004) Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes. Br J Pharmacol, 143, 803-818.
17. Calzolai L, Lysek DA, Perez DR, Guntert P, and Wuthrich K (2005) Prion protein NMR structures of chickens, turtles, and frogs. Proc Natl Acad Sci U S A, 102, 651-655.
18. Caughey B, Brown K, Raymond GJ, Katzenstein GE, and Thresher W (1994) Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and congo red [corrected]. J Virol, 68, 2135-2141.
19. Caughey B, Caughey WS, Kocisko DA, Lee KS, Silveira JR, and Morrey JD (2006) Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds? Acc Chem Res, 39, 646-653.
20. Chao MV (2003) Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci, 4, 299-309.
21. Chao MV and Bothwell M (2002) Neurotrophins: to cleave or not to cleave. Neuron, 33, 9-12.
22. Chen S, Mange A, Dong L, Lehmann S, and Schachner M (2003) Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal survival. Mol Cell Neurosci, 22, 227-233.
23. Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P, and utilio-Gambetti L (1995) Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem, 270, 19173-19180.
24. Chiarini LB, Freitas AR, Zanata SM, Brentani RR, Martins VR, and Linden R (2002) Cellular prion protein transduces neuroprotective signals. EMBO J, 21, 3317-3326.
25. Cisse MA, Sunyach C, Lefranc-Jullien S, Postina R, Vincent B, and Checler F (2005) The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity. J Biol Chem, 280, 40624-40631.
26. Clegg DO, Wingerd KL, Hikita ST, and Tolhurst EC (2003) Integrins in the development, function and dysfunction of the nervous system. Front Biosci, 8, d723-d750.
27. Coitinho AS, Freitas AR, Lopes MH, Hajj GN, Roesler R, Walz R, Rossato JI, Cammarota M, Izquierdo I, Martins VR, and Brentani RR (2006) The interaction between prion protein and laminin modulates memory consolidation. Eur J Neurosci, 24, 3255-3264.
28. Coitinho AS, Lopes MH, Hajj GN, Rossato JI, Freitas AR, Castro CC, Cammarota M, Brentani RR, Izquierdo I, and Martins VR (2007) Short-term memory formation and long-term memory consolidation are enhanced by cellular prion association to stress-inducible protein 1. Neurobiol Dis, 26, 282-290.
29. Coitinho AS, Roesler R, Martins VR, Brentani RR, and Izquierdo I (2003) Cellular prion protein ablation impairs behavior as a function of age. Neuroreport, 14, 1375-1379.
30. Colling SB, Collinge J, and Jefferys JG (1996) Hippocampal slices from prion protein null mice: disrupted Ca(2+)-activated K+ currents. Neurosci Lett, 209, 49-52.
31. Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR, and Jefferys JG (1994) Prion protein is necessary for normal synaptic function. Nature, 370, 295-297.
32. Colognato H, ffrench-Constant C, and Feltri ML (2005) Human diseases reveal novel roles for neural laminins. Trends Neurosci, 28, 480-486.
33. Colognato H and Yurchenco PD (2000) Form and function: the laminin family of heterotrimers. Dev Dyn, 218, 213-234.
34. Conese M, Nykjaer A, Petersen CM, Cremona O, Pardi R, Andreasen PA, Gliemann J, Christensen EI, and Blasi F (1995) alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor. J Cell Biol, 131, 1609-1622.
35. Cosker KE, Courchesne SL, and Segal RA (2008) Action in the axon: generation and transport of signaling endosomes. Curr Opin Neurobiol. 18, 270-275.
36. Coulpier M, Messiaen S, Boucreaux D, and Eloit M (2006) Axotomy-induced motoneuron death is delayed in mice overexpressing PrPc. Neuroscience, 141, 1827-1834.
37. Criado JR, Sanchez-Alavez M, Conti B, Giacchino JL, Wills DN, Henriksen SJ, Race R, Manson JC, Chesebro B, and Oldstone MB (2005) Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol Dis, 19, 255-265.
38. Czekay RP, Kuemmel TA, Orlando RA, and Farquhar MG (2001) Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity. Mol Biol Cell, 12, 1467-1479.
39. Danielisova V, Gottlieb M, Nemethova M, and Burda J (2008) Effects of bradykinin postconditioning on endogenous antioxidant enzyme activity after transient forebrain ischemia in rat. Neurochem Res, 33, 1057-1064.
40. Datson NA, Morsink MC, Meijer OC, and de Kloet ER (2008) Central corticosteroid actions: Search for gene targets. Eur J Pharmacol, 583, 272-289.
41. Davies AM (1996) The neurotrophic hypothesis: where does it stand? Philos Trans R Soc Lond B Biol Sci, 351, 389-394.
42. de Almeida CJ, Chiarini LB, da Silva JP, PM ES, Martins MA, and Linden R (2005) The cellular prion protein modulates phagocytosis and inflammatory response. J Leukoc Biol, 77, 238-246.
43. De AA and Georges-Labouesse E (2000) Integrin and ECM functions: roles in vertebrate development. Trends Genet, 16, 389-395.
44. DeArmond SJ, Qiu Y, Sanchez H, Spilman PR, Ninchak-Casey A, Alonso D, and Daggett V (1999) PrPc glycoform heterogeneity as a function of brain region: implications for selective targeting of neurons by prion strains. J Neuropathol Exp Neurol, 58, 1000-1009.
45. DeArmond SJ, Sanchez H, Yehiely F, Qiu Y, Ninchak-Casey A, Daggett V, Camerino AP, Cayetano J, Rogers M, Groth D, Torchia M, Tremblay P, Scott MR, Cohen FE, and Prusiner SB (1997) Selective neuronal targeting in prion disease. Neuron, 19, 1337-1348.
46. Denda S and Reichardt LF (2007) Studies on integrins in the nervous system. Methods Enzymol, 426, 203-221.
47. Ditlevsen DK, Povlsen GK, Berezin V, and Bock E (2008) NCAM-induced intracellular signaling revisited. J Neurosci Res, 86, 727-743.
48. Dohlman HG (2008) A scaffold makes the switch. Sci Signal, 1, e46.
49. Dupuis L, Mbebi C, Gonzalez de Aguilar JL, Rene F, Muller A, de TM, and Loeffler JP (2002) Loss of prion protein in a transgenic model of amyotrophic lateral sclerosis. Mol Cell Neurosci, 19, 216-224.
50. Eberl H, Tittmann P, and Glockshuber R (2004) Characterization of recombinant, membrane-attached full-length prion protein. J Biol Chem, 279, 25058-25065.
51. Fagan KA, Graf RA, Tolman S, Schaack J, and Cooper DM (2000) Regulation of a Ca2+-sensitive adenylyl cyclase in an excitable cell. Role of voltage-gated versus capacitative Ca2+ entry. J Biol Chem, 275, 40187-40194.
52. Ferguson SS (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev, 53, 1-24.
53. Fevrier B, Vilette D, Archer F, Loew D, Faigle W, Vidal M, Laude H, and Raposo G (2004) Cells release prions in association with exosomes. Proc Natl Acad Sci U S A, 101, 9683-9688.
54. Fink M, Duprat F, Lesage F, Reyes R, Romey G, Heurteaux C, and Lazdunski M (1996) Cloning, functional expression and brain localization of a novel unconventional outward rectifier K+ channel. EMBO J, 15, 6854-6862.
55. Fivaz M, Vilbois F, Thurnheer S, Pasquali C, Abrami L, Bickel PE, Parton RG, and van der Goot FG (2002) Differential sorting and fate of endocytosed GPI-anchored proteins. EMBO J, 21, 3989-4000.
56. Franks NP and Honore E (2004) The TREK K2P channels and their role in general anaesthesia and neuroprotection. Trends Pharmacol Sci, 25, 601-608.
57. Freire E, Gomes FC, Linden R, Neto VM, and Coelho-Sampaio T (2002) Structure of laminin substrate modulates cellular signaling for neuritogenesis. J Cell Sci, 115, 4867-4876.
58. Fuhrmann M, Bittner T, Mitteregger G, Haider N, Moosmang S, Kretzschmar H, and Herms J (2006) Loss of the cellular prion protein affects the Ca2+ homeostasis in hippocampal CA1 neurons. J Neurochem, 98, 1876-1885.
59. Gauczynski S, Peyrin JM, Haik S, Leucht C, Hundt C, Rieger R, Krasemann S, Deslys JP, Dormont D, Lasmezas CI, and Weiss S (2001) The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J, 20, 5863-5875.
60. Giacomello M, Drago I, Pizzo P, and Pozzan T (2007) Mitochondrial Ca2+ as a key regulator of cell life and death. Cell Death Differ, 14, 1267-1274.
61. Gorodinsky A and Harris DA (1995) Glycolipid-anchored proteins in neuroblastoma cells form detergent-resistant complexes without caveolin. J Cell Biol, 129, 619-627.
62. Graner E, Mercadante AF, Zanata SM, Forlenza OV, Cabral AL, Veiga SS, Juliano MA, Roesler R, Walz R, Minetti A, Izquierdo I, Martins VR, and Brentani, RR (2000a) Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res Mol Brain Res, 76, 85-92.
63. Graner E, Mercadante AF, Zanata SM, Martins VR, Jay DG, and Brentani RR (2000b) Laminin-induced PC-12 cell differentiation is inhibited following laser inactivation of cellular prion protein. FEBS Lett, 482, 257-260.
64. Grimpe B and Silver J (2002) The extracellular matrix in axon regeneration. Prog Brain Res, 137, 333-349.
65. Hajj GN, Lopes MH, Mercadante AF, Veiga SS, da Silveira RB, Santos TG, Ribeiro KC, Juliano MA, Jacchieri SG, Zanata SM, and Martins VR (2007) Cellular prion protein interaction with vitronectin supports axonal growth and is compensated by integrins. J Cell Sci, 120, 1915-1926.
66. Haraguchi T, Fisher S, Olofsson S, Endo T, Groth D, Tarentino A, Borchelt DR, Teplow D, Hood L, Burlingame A, and . (1989) Asparagine-linked glycosylation of the scrapie and cellular prion proteins. Arch Biochem Biophys, 274, 1-13.
67. Harris DA, Huber MT, van DP, Shyng SL, Chait BT, and Wang R (1993) Processing of a cellular prion protein: identification of N- and C-terminal cleavage sites. Biochemistry, 32, 1009-1016.
68. Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, Torchia M, DeArmond SJ, Prusiner SB, and Lingappa VR (1998) A transmembrane form of the prion protein in neurodegenerative disease. Science, 279, 827-834.
69. Heppner FL, Musahl C, Arrighi I, Klein MA, Rulicke T, Oesch B, Zinkernagel RM, Kalinke U, and Aguzzi A (2001) Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science, 294, 178-182.
70. Herms JW, Korte S, Gall S, Schneider I, Dunker S, and Kretzschmar HA (2000) Altered intracellular calcium homeostasis in cerebellar granule cells of prion protein-deficient mice. J Neurochem, 75, 1487-1492.
71. Herms JW, Tings T, Dunker S, and Kretzschmar HA (2001) Prion protein affects Ca2+-activated K+ currents in cerebellar purkinje cells. Neurobiol Dis, 8, 324-330.
72. Hicks MR, Gill AC, Bath IK, Rullay AK, Sylvester ID, Crout DH, and Pinheiro TJ (2006) Synthesis and structural characterization of a mimetic membrane-anchored prion protein. FEBS J, 273, 1285-1299.
73. Hisata S, Sakisaka T, Baba T, Yamada T, Aoki K, Matsuda M, and Takai Y (2007) Rap1-PDZ-GEF1 interacts with a neurotrophin receptor at late endosomes, leading to sustained activation of Rap1 and ERK and neurite outgrowth. J Cell Biol, 178, 843-860.
74. Hornemann S, Schorn C, and Wuthrich K (2004) NMR structure of the bovine prion protein isolated from healthy calf brains. EMBO Rep, 5, 1159-1164.
75. Hossain WA, D'Sa C, and Morest DK (2008) Interactive roles of fibroblast growth factor 2 and neurotrophin 3 in the sequence of migration, process outgrowth, and axonal differentiation of mouse cochlear ganglion cells. J Neurosci Res, 86, 2376-2391.
76. Howe CL and Mobley WC (2005) Long-distance retrograde neurotrophic signaling. Curr Opin Neurobiol, 15, 40-48.
77. Huang EJ and Reichardt LF (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem, 72, 609-642.
78. Hundt C, Peyrin JM, Haik S, Gauczynski S, Leucht C, Rieger R, Riley ML, Deslys JP, Dormont D, Lasmezas CI, and Weiss S (2001) Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor. EMBO J, 20, 5876-5886.
79. Ibanez CF (2007) Message in a bottle: long-range retrograde signaling in the nervous system. Trends Cell Biol, 17, 519-528.
80. Iida J, Ishizaki H, Okamoto-Tanaka M, Kawata A, Sumita K, Ohgake S, Sato Y, Yorifuji H, Nukina N, Ohashi K, Mizuno K, Tsutsumi T, Mizoguchi A, Miyoshi J, Takai Y, and Hata Y (2007) Synaptic scaffolding molecule alpha is a scaffold to mediate N-methyl-D-aspartate receptor-dependent RhoA activation in dendrites. Mol Cell Biol, 27, 4388-4405.
81. Iwakura Y, Nawa H, Sora I, and Chao MV (2008) Dopamine D1 receptor-induced signaling through TrkB receptors in striatal neurons. J Biol Chem, 283, 1579915806.
82. Jarnaess E and Tasken K (2007) Spatiotemporal control of cAMP signalling processes by anchored signalling complexes. Biochem Soc Trans, 35, 931-937.
83. Jeanneteau F, Garabedian MJ, and Chao MV (2008) Activation of Trk neurotrophin receptors by glucocorticoids provides a neuroprotective effect. Proc Natl Acad Sci U S A, 105, 4862-4867.
84. Jodoin J, Laroche-Pierre S, Goodyer CG, and Leblanc AC (2007) Defective retrotranslocation causes loss of anti-Bax function in human familial prion protein mutants. J Neurosci, 27, 5081-5091.
85. Kalb R (2005) The protean actions of neurotrophins and their receptors on the life and death of neurons. Trends Neurosci, 28, 5-11.
86. Kanaani J, Prusiner SB, Diacovo J, Baekkeskov S, and Legname G (2005) Recombinant prion protein induces rapid polarization and development of synapses in embryonic rat hippocampal neurons in vitro. J Neurochem, 95, 13731386.
87. Katanaev VL, Solis GP, Hausmann G, Buestorf S, Katanayeva N, Schrock Y, Stuermer CA, and Basler K (2008) Reggie-1/flotillin-2 promotes secretion of the long-range signalling forms of Wingless and Hedgehog in Drosophila. EMBO J, 27, 5309-521.
88. Khosravani H, Zhang Y, Tsutsui S, Hameed S, Altier C, Hamid J, Chen L, Villemaire M, Ali Z, Jirik FR, and Zamponi GW (2008) Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Cell Biol, 181, 551-565.
89. Kleene R, Loers G, Langer J, Frobert Y, Buck F, and Schachner M (2007) Prion protein regulates glutamate-dependent lactate transport of astrocytes. J Neurosci, 27, 12331-12340.
90. Kocisko DA, Vaillant A, Lee KS, Arnold KM, Bertholet N, Race RE, Olsen EA, Juteau JM, and Caughey B (2006) Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides. Antimicrob Agents Chemother, 50, 10341044.
91. Kong Q, Surewicz WK, Petersen RB, Zou W, Chen SG, Gambetti P, Parchi P, Capellari S, Goldfarb L, Montagna P, Lugaresi E, Piccardo P, and Ghetti B (2003). Inherited Prion Diseases. In Stanley B Prusiner (Ed.), Prion Biology and Diseases, . John Inglis, pp. 673-775.
92. Krieglstein K and Unsicker K (1996) Proteins from chromaffin granules promote survival of dorsal root ganglionic neurons: comparison with neurotrophins. Brain Res Dev Brain Res, 93, 10-17.
93. Kristensson K, Feuerstein B, Taraboulos A, Hyun WC, Prusiner SB, and DeArmond SJ (1993) Scrapie prions alter receptor-mediated calcium responses in cultured cells. Neurology, 43, 2335-2341.
94. Kurisaki A, Inoue I, Kurisaki K, Yamakawa N, Tsuchida K, and Sugino H (2008) Activin induces long-lasting N-methyl-Daspartate receptor activation via scaffolding PDZ protein activin receptor interacting protein 1. Neuroscience, 151, 1225-1235.
95. Kuwahara C, Takeuchi AM, Nishimura T, Haraguchi K, Kubosaki A, Matsumoto Y, Saeki K, Matsumoto Y, Yokoyama T, Itohara S, and Onodera T (1999) Prions prevent neuronal cell-line death. Nature, 400, 225-226.
96. Laffont-Proust I, Faucheux BA, Hassig R, Sazdovitch V, Simon S, Grassi J, Hauw JJ, Moya KL, and Haik S (2005) The N-terminal cleavage of cellular prion protein in the human brain. FEBS Lett, 579, 6333-6337.
97. Landolt HP, Glatzel M, Blattler T, Achermann P, Roth C, Mathis J, Weis J, Tobler I, Aguzzi A, and Bassetti CL (2006) Sleep-wake disturbances in sporadic Creutzfeldt-Jakob disease. Neurology, 66, 1418-1424.
98. Lauren J, Gimbel DA, Nygaard HB, Gilbert JW, and Strittmatter SM (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature, 457, 1128-1132.
99. Lee FS, Rajagopal R, Kim AH, Chang PC, and Chao MV (2002) Activation of Trk neurotrophin receptor signaling by pituitary adenylate cyclase-activating polypeptides. J Biol Chem, 277, 9096-9102.
100. Lee KJ, Panzera A, Rogawski D, Greene LE, and Eisenberg E (2007a) Cellular prion protein (PrPC) protects neuronal cells from the effect of huntingtin aggregation. J Cell Sci, 120, 2663-2671.
101. Lee KS, Magalhaes AC, Zanata SM, Brentani RR, Martins VR, and Prado MA (2001) Internalization of mammalian fluorescent cellular prion protein and N-terminal deletion mutants in living cells. J Neurochem, 79, 79-87.
102. Lee KS, Raymond LD, Schoen B, Raymond GJ, Kett L, Moore RA, Johnson LM, Taubner L, Speare JO, Onwubiko HA, Baron GS, Caughey WS, and Caughey B (2007b) Hemin interactions and alterations of the subcellular localization of prion protein. J Biol Chem, 282, 36525-36533.
103. Lefebvre-Roque M, Kremmer E, Gilch S, Zou WQ, Feraudet C, Gilles CM, Sales N, Grassi J, Gambetti P, Baron T, Schatzl H, and Lasmezas CI (2007) Toxic effects of intracerebral PrP antibody administration during the course of BSE infection in mice. Prion, 1, 198-206.
104. Levi-Montalcini R (1987) The nerve growth factor 35 years later. Science, 237, 1154-1162.
105. Levi-Montalcini R and Calissano P (2006) The scientific challenge of the 21st century: from a reductionist to a holistic approach via systems biology. BMC Neurosci, 7 Suppl 1, S1.
106. Levi-Montalcini R, Skaper SD, Dal TR, Petrelli L, and Leon A (1996) Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci, 19, 514-520.
107. Levine JM (1992) Historical perspective: the neurotrophic theory of skin ulceration. J Am Geriatr Soc, 40, 1281-1283.
108. Li A, Christensen HM, Stewart LR, Roth KA, Chiesa R, and Harris DA (2007) Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105-125. EMBO J, 26, 548-558.
109. Liesi P, Narvanen A, Soos J, Sariola H, and Snounou G (1989) Identification of a neurite outgrowth-promoting domain of laminin using synthetic peptides. FEBS Lett, 244, 141-148.
110. Lima FR, Arantes CP, Muras AG, Nomizo R, Brentani RR, and Martins VR (2007) Cellular prion protein expression in astrocytes modulates neuronal survival and differentiation. J Neurochem. 103, 2164-2176.
111. Linden R (1994) The survival of developing neurons: a review of afferent control. Neuroscience, 58, 671-682.
112. Linden R, Martins RA, and Silveira MS (2005) Control of programmed cell death by neurotransmitters and neuropeptides in the developing mammalian retina. Prog Retin Eye Res, 24, 457-491.
113. Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, and Brentani RR (2008) Physiology of the prion protein. Physiol Rev, 88, 673-728.
114. Lopes MH, Hajj GN, Muras AG, Mancini GL, Castro RM, Ribeiro KC, Brentani RR, Linden R, and Martins VR (2005) Interaction of cellular prion and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling pathways. J Neurosci, 25, 11330-11339.
115. Lopez GF, Zahn R, Riek R, and Wuthrich K (2000) NMR structure of the bovine prion protein. Proc Natl Acad Sci U S A, 97, 8334-8339.
116. Luckenbill-Edds L (1997) Laminin and the mechanism of neuronal outgrowth. Brain Res Brain Res Rev, 23, 1-27.
117. Lysek DA, Schorn C, Nivon LG, Esteve-Moya V, Christen B, Calzolai L, von SC, Fiorito F, Herrmann T, Guntert P, and Wuthrich K (2005) Prion protein NMR structures of cats, dogs, pigs, and sheep. Proc Natl Acad Sci U S A, 102, 640-645.
118. Magalhaes AC, Silva JA, Lee KS, Martins VR, Prado VF, Ferguson SS, Gomez MV, Brentani RR, and Prado MA (2002) Endocytic intermediates involved with the intracellular trafficking of a fluorescent cellular prion protein. J Biol Chem, 277, 33311-33318.
119. Maglio LE, Perez MF, Martins VR, Brentani RR, and Ramirez OA (2004) Hippocampal synaptic plasticity in mice devoid of cellular prion protein. Brain Res Mol Brain Res, 131, 58-64.
120. Malaga-Trillo E, Solis GP, Schrock Y, Geiss C, Luncz L, Thomanetz V, and Stuermer CA (2009) Regulation of embryonic cell adhesion by the prion protein. PLoS Biol, 7, e55.
121. Mallucci GR, Ratte S, Asante EA, Linehan J, Gowland I, Jefferys JG, and Collinge J (2002) Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J, 21, 202-210.
122. Mallucci G, Dickinson A, Linehan J, Klohn PC, Brandner S, and Collinge J (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science, 302, 871-874.
123. Mallucci GR, White MD, Farmer M, Dickinson A, Khatun H, Powell AD, Brandner S, Jefferys JG, and Collinge J (2007) Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron, 53, 325-335.
124. Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, and Hope J (1994) 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol, 8, 121-127.
125. Marchi S, Rimessi A, Giorgi C, Baldini C, Ferroni L, Rizzuto R, and Pinton P (2008) Akt kinase reducing endoplasmic reticulum Ca2+ release protects cells from Ca2+-dependent apoptotic stimuli. Biochem Biophys Res Commun, 375, 501-505.
126. Martins AH, Resende RR, Majumder P, Faria M, Casarini DE, Tarnok A, Colli W, Pesquero JB, and Ulrich H (2005) Neuronal differentiation of P19 embryonal carcinoma cells modulates kinin B2 receptor gene expression and function. J Biol Chem, 280, 19576-19586.
127. Martins RA and Pearson RA (2008) Control of cell proliferation by neurotransmitters in the developing vertebrate retina. Brain Res, 1192, 37-60.
128. Martins VR, Graner E, Garcia-Abreu J, de Souza SJ, Mercadante AF, Veiga SS, Zanata SM, Neto VM, and Brentani RR (1997) Complementary hydropathy identifies a cellular prion protein receptor. Nat Med, 3, 1376-1382.
129. Martins VR, Linden R, Prado MA, Walz R, Sakamoto AC, Izquierdo I, and Brentani RR (2002) Cellular prion protein: on the road for functions. FEBS Lett, 512, 25-28.
130. Masters CL, Gajdusek DC, and Gibbs CJ, Jr. (1981) Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Straussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain, 104, 559-588.
131. Mattei V, Barenco MG, Tasciotti V, Garofalo T, Longo A, Boller K, Lower J, Misasi R, Montrasio F, and Sorice M (2009) Paracrine diffusion of PrP(C) and propagation of prion infectivity by plasma membrane-derived microvesicles. PLoS One, 4, e5057.
132. McLennan NF, Brennan PM, McNeill A, Davies I, Fotheringham A, Rennison KA, Ritchie D, Brannan F, Head MW, Ironside JW, Williams A, and Bell JE (2004) Prion protein accumulation and neuroprotection in hypoxic brain damage. Am J Pathol, 165, 227-235.
133. Meldrum BS (2000) Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr, 130, 1007S-1015S.
134. Middleton G, Hamanoue M, Enokido Y, Wyatt S, Pennica D, Jaffray E, Hay RT, and Davies AM (2000) Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons. J Cell Biol, 148, 325-332.
135. Mitsios N, Saka M, Krupinski J, Pennucci R, Sanfeliu C, Miguel TM, Gaffney J, Kumar P, Kumar S, Sullivan M, and Slevin M (2007) Cellular prion protein is increased in the plasma and peri-infarcted brain tissue after acute stroke. J Neurosci Res, 85, 602-611.
136. Moreno DH (1999) Molecular and functional diversity of voltage-gated calcium channels. Ann N Y Acad Sci, 868, 102-117.
137. Morillas M, Swietnicki W, Gambetti P, and Surewicz WK (1999) Membrane environment alters the conformational structure of the recombinant human prion protein. J Biol Chem, 274, 36859-36865.
138. Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, and Kellermann O (2000) Signal transduction through prion protein. Science, 289, 1925-1928.
139. Mouillet-Richard S, Pietri M, Schneider B, Vidal C, Mutel V, Launay JM, and Kellermann O (2005) Modulation of serotonergic receptor signaling and crosstalk by prion protein. J Biol Chem, 280, 4592-4601.
140. Mouillet-Richard S, Schneider B, Pradines E, Pietri M, Ermonval M, Grassi J, Richards JG, Mutel V, Launay JM, and Kellermann O (2007) Cellular prion protein signaling in serotonergic neuronal cells. Ann N Y Acad Sci, 1096, 106-119.
141. Muramoto T, DeArmond SJ, Scott M, Telling GC, Cohen FE, and Prusiner SB (1997) Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an alpha-helix. Nat Med, 3, 750-755.
142. Murrin LC and Talbot JN (2007) RanBPM, a scaffolding protein in the immune and nervous systems. J Neuroimmune Pharmacol, 2, 290-295.
143. Nagappan G and Lu B (2005) Activity-dependent modulation of the BDNF receptor TrkB: mechanisms and implications. Trends Neurosci, 28, 464-471.
144. Nakaoka Y, Nishida K, Fujio Y, Izumi M, Terai K, Oshima Y, Sugiyama S, Matsuda S, Koyasu S, Yamauchi-Takihara K, Hirano T, Kawase I, and Hirota H (2003) Activation of gp130 transduces hypertrophic signal through interaction of scaffolding/docking protein Gab1 with tyrosine phosphatase SHP2 in cardiomyocytes. Circ Res, 93, 221-229.
145. Naslavsky N, Stein R, Yanai A, Friedlander G, and Taraboulos A (1997) Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J Biol Chem, 272, 6324-6331.
146. Nazor KE, Seward T, and Telling GC (2007) Motor behavioral and neuropathological deficits in mice deficient for normal prion protein expression. Biochim Biophys Acta, 1772, 645-653.
147. Nelson J, McFerran NV, Pivato G, Chambers E, Doherty C, Steele D, and Timson DJ (2008) The 67 kDa laminin receptor: structure, function and role in disease. Biosci Rep, 28, 33-48.
148. Nichols BJ, Kenworthy AK, Polishchuk RS, Lodge R, Roberts TH, Hirschberg K, Phair RD, and Lippincott-Schwartz J (2001) Rapid cycling of lipid raft markers between the cell surface and Golgi complex. J Cell Biol, 153, 529-541.
149. Nishimura T, Sakudo A, Nakamura I, Lee DC, Taniuchi Y, Saeki K, Matsumoto Y, Ogawa M, Sakaguchi S, Itohara S, and Onodera T (2004) Cellular prion protein regulates intracellular hydrogen peroxide level and prevents copperinduced apoptosis. Biochem Biophys Res Commun, 323, 218-222.
150. Nykjaer A, Petersen CM, Moller B, Jensen PH, Moestrup SK, Holtet TL, Etzerodt M, Thogersen HC, Munch M, Andreasen PA, and . (1992) Purified alpha 2macroglobulin receptor/LDL receptor-related protein binds urokinase. plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J Biol Chem, 267, 14543-14546.
151. Oppenheim RW (1989) The neurotrophic theory and naturally occurring motoneuron death. Trends Neurosci, 12, 252-255.
152. Pantera B, Bini C, Cirri P, Paoli P, Camici G, Manao G, and Caselli A (2009) PrPc activation induces neurite outgrowth and differentiation in PC12 cells: role for caveolin-1 in the signal transduction pathway. J Neurochem, 110, 194-207.
153. Parizek P, Roeckl C, Weber J, Flechsig E, Aguzzi A, and Raeber AJ (2001) Similar turnover and shedding of the cellular prion protein in primary lymphoid and neuronal cells. J Biol Chem, 276, 44627-44632.
154. Parkin ET, Watt NT, Hussain I, Eckman EA, Eckman CB, Manson JC, Baybutt HN, Turner AJ, and Hooper NM (2007) Cellular prion protein regulates betasecretase cleavage of the Alzheimer's amyloid precursor protein. Proc Natl Acad Sci U S A, 104, 11062-11067.
155. Parkin ET, Watt NT, Turner AJ, and Hooper NM (2004) Dual mechanisms for shedding of the cellular prion protein. J Biol Chem, 279, 11170-11178.
156. Parkyn CJ, Vermeulen EG, Mootoosamy RC, Sunyach C, Jacobsen C, Oxvig C, Moestrup S, Liu Q, Bu G, Jen A, and Morris RJ (2008) LRP1 controls biosynthetic and endocytic trafficking of neuronal prion protein. J Cell Sci, 121, 773-783.
157. Patel AJ and Honore E (2001) Properties and modulation of mammalian 2P domain K+ channels. Trends Neurosci, 24, 339-346.
158. Pauly PC and Harris DA (1998) Copper stimulates endocytosis of the prion protein. J Biol Chem, 273, 33107-33110.
159. Pawson T and Scott JD (1997) Signaling through scaffold, anchoring, and adaptor proteins. Science, 278, 2075-2080.
160. Perera WS and Hooper NM (2001) Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region. Curr Biol, 11, 519-523.
161. Perini F, Frangione B, and Prelli F (1996) Prion protein released by platelets. Lancet, 347, 1635-1636.
162. Ping A, Chun ZX, and Xue XY (2005) Bradykinin preconditioning induces protective effects against focal cerebral ischemia in rats. Brain Res, 1059, 105-112.
163. Pires Neto MA, Braga-de-Souza S, and Lent R (1999) Extracellular matrix molecules play diverse roles in the growth and guidance of central nervous system axons. Braz J Med Biol Res, 32, 633-638.
164. Pons S and Marti E (2000) Sonic hedgehog synergizes with the extracellular matrix protein vitronectin to induce spinal motor neuron differentiation. Development, 127, 333-342.
165. Pons S, Trejo JL, Martinez-Morales JR, and Marti E (2001) Vitronectin regulates Sonic hedgehog activity during cerebellum development through CREB phosphorylation. Development, 128, 1481-1492.
166. Pradines E, Loubet D, Schneider B, Launay JM, Kellermann O, and Mouillet-Richard S (2008) CREB-dependent gene regulation by prion protein: Impact on MMP-9 and beta-dystroglycan. Cell Signal, 20, 2050-2058.
167. Prado MA, ves-Silva J, Magalhaes AC, Prado VF, Linden R, Martins VR, and Brentani RR (2004) PrPc on the road: trafficking of the cellular prion protein. J Neurochem, 88, 769-781.
168. Prestori F, Rossi P, Bearzatto B, Laine J, Necchi D, Diwakar S, Schiffmann SN, Axelrad H, and D'Angelo E (2008) Altered neuron excitability and synaptic plasticity in the cerebellar granular layer of juvenile prion protein knockout mice with impaired motor control. J Neurosci, 28, 7091-7103.
169. Priola SA and Caughey B (1994) Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis. Mol Neurobiol, 8, 113-120.
170. Provini F, Vetrugno R, Pierangeli G, Cortelli P, Rizzo G, Filla A, Strisciuglio C, Gallassi R, and Montagna P (2008) Sleep and temperature rhythms in two sisters with P102L Gerstmann-Straussler-Scheinker (GSS) disease. Sleep Med. 10, 374-377.
171. Radovanovic I, Braun N, Giger OT, Mertz K, Miele G, Prinz M, Navarro B, and Aguzzi A (2005) Truncated prion protein and Doppel are myelinotoxic in the absence of oligodendrocytic PrPC. J Neurosci, 25, 4879-4888.
172. Rambold AS, Muller V, Ron U, Ben-Tal N, Winklhofer KF, and Tatzelt J (2008) Stress-protective signalling of prion protein is corrupted by scrapie prions. EMBO J, 27, 1974-1984.
173. Rangel A, Burgaya F, Gavin R, Soriano E, Aguzzi A, and Del Rio JA (2007) Enhanced susceptibility of Prnp-deficient mice to kainate-induced seizures, neuronal apoptosis, and death: Role of AMPA/kainate receptors. J Neurosci Res, 85, 2741-2755.
174. Rauch U (2004) Extracellular matrix components associated with remodeling processes in brain. Cell Mol Life Sci, 61, 2031-2045.
175. Rieger R, Edenhofer F, Lasmezas CI, and Weiss S (1997) The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat Med, 3, 1383-1388.
176. Riek R, Hornemann S, Wider G, Glockshuber R, and Wuthrich K (1997) NMR characterization of the full-length recombinant murine prion protein, mPrP(23231). FEBS Lett, 413, 282-288.
177. Robertson C, Booth SA, Beniac DR, Coulthart MB, Booth TF, and McNicol A (2006) Cellular prion protein is released on exosomes from activated platelets. Blood, 107, 3907-3911.
178. Rodriguez MM, Peoc'h K, Haik S, Bouchet C, Vernengo L, Manana G, Salamano R, Carrasco L, Lenne M, Beaudry P, Launay JM, and Laplanche JL (2005) A novel mutation (G114V) in the prion protein gene in a family with inherited prion disease. Neurology, 64, 1455-1457.
179. Rudd PM, Endo T, Colominas C, Groth D, Wheeler SF, Harvey DJ, Wormald MR, Serban H, Prusiner SB, Kobata A, and Dwek RA (1999) Glycosylation differences between the normal and pathogenic prion protein isoforms. Proc Natl Acad Sci U S A, 96, 13044-13049.
180. Runeberg-Roos P and Saarma M (2007) Neurotrophic factor receptor RET: structure, cell biology, and inherited diseases. Ann Med, 39, 572-580.
181. Sadowski MJ, Pankiewicz J, Prelli F, Scholtzova H, Spinner DS, Kascsak RB, Kascsak RJ, and Wisniewski T (2009) Anti-PrP Mab 6D11 suppresses PrP(Sc) replication in prion infected myeloid precursor line FDC-P1/22L and in the lymphoreticular system in vivo. Neurobiol Dis, 34, 267-278.
182. Sadri-Vakili G and Cha JH (2006) Histone deacetylase inhibitors: a novel therapeutic approach to Huntington's disease (complex mechanism of neuronal death). Curr Alzheimer Res, 3, 403-408.
183. Samaia HB and Brentani RR (1998) Can loss-of-function prion-related diseases exist? Mol Psychiatry, 3, 196-197.
184. Sanford SD, Gatlin JC, Hokfelt T, and Pfenninger KH (2008) Growth cone responses to growth and chemotropic factors. Eur J Neurosci, 28, 268-278.
185. Santuccione A, Sytnyk V, Leshchyns'ka I, and Schachner M (2005) Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J Cell Biol, 169, 341-354.
186. Sariola H and Saarma M (2003) Novel functions and signalling pathways for GDNF. J Cell Sci, 116, 3855-3862.
187. Schmitt-Ulms G, Legname G, Baldwin MA, Ball HL, Bradon N, Bosque PJ, Crossin KL, Edelman GM, DeArmond SJ, Cohen FE, and Prusiner SB (2001) Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol, 314, 1209-1225.
188. Schonberger O, Horonchik L, Gabizon R, Papy-Garcia D, Barritault D, and Taraboulos A (2003) Novel heparan mimetics potently inhibit the scrapie prion protein and its endocytosis. Biochem Biophys Res Commun, 312, 473-479.
189. Schrock Y, Solis GP, and Stuermer CA (2009) Regulation of focal adhesion formation and filopodia extension by the cellular prion protein (PrPC). FEBS Lett, 583, 389-393.
190. Sharma HS (2007) A select combination of neurotrophins enhances neuroprotection and functional recovery following spinal cord injury. Ann N Y Acad Sci, 1122, 95-111.
191. Shmerling D, Hegyi I, Fischer M, Blattler T, Brandner S, Gotz J, Rulicke T, Flechsig E, Cozzio A, von MC, Hangartner C, Aguzzi A, and Weissmann C (1998) Expression of aminoterminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell, 93, 203-214.
192. Shyng SL, Heuser JE, and Harris DA (1994) A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits. J Cell Biol, 125, 1239-1250.
193. Shyu WC, Lin SZ, Chiang MF, Ding DC, Li KW, Chen SF, Yang HI, and Li H (2005) Overexpression of PrPC by adenovirus-mediated gene targeting reduces ischemic injury in a stroke rat model. J Neurosci, 25, 8967-8977.
194. Silva JL, Lima LM, Foguel D, and Cordeiro Y (2008) Intriguing nucleic-acidbinding features of mammalian prion protein. Trends Biochem Sci, 33, 132-140.
195. Solforosi L, Criado JR, McGavern DB, Wirz S, Sanchez-Alavez M, Sugama S, DeGiorgio LA, Volpe BT, Wiseman E, Abalos G, Masliah E, Gilden D, Oldstone MB, Conti B, and Williamson RA (2004) Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science, 303, 1514-1516.
196. Spudich A, Frigg R, Kilic E, Kilic U, Oesch B, Raeber A, Bassetti CL, and Hermann DM (2005) Aggravation of ischemic brain injury by prion protein deficiency: role of ERK-1/-2 and STAT-1. Neurobiol Dis, 20, 442-449.
197. Stuermer CA, Langhorst MF, Wiechers MF, Legler DF, Von Hanwehr SH, Guse AH, and Plattner H (2004) PrPc capping in T cells promotes its association with the lipid raft proteins reggie-1 and reggie-2 and leads to signal transduction. FASEB J, 18, 1731-1733.
198. Stuermer CA and Plattner H (2005) The 'lipid raft' microdomain proteins reggie-1 and reggie-2 (flotillins) are scaffolds for protein interaction and signalling. Biochem Soc Symp, 109-118.
199. Sunyach C, Cisse MA, da Costa CA, Vincent B, and Checler F (2007) The C-terminal products of cellular prion protein processing, C1 and C2, exert distinct influence on p53-dependent staurosporine-induced caspase-3 activation. J Biol Chem, 282, 1956-1963.
200. Sunyach C, Jen A, Deng J, Fitzgerald KT, Frobert Y, Grassi J, McCaffrey MW, and Morris R (2003) The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein. EMBO J, 22, 3591-3601.
201. Tagliavini F, Prelli F, Porro M, Salmona M, Bugiani O, and Frangione B (1992) A soluble form of prion protein in human cerebrospinal fluid: implications for prion-related encephalopathies. Biochem Biophys Res Commun, 184, 1398-1404.
202. Tayebi M and Hawke S (2006) Antibody-mediated neuronal apoptosis: therapeutic implications for prion diseases. Immunol Lett, 105, 123-126.
203. Taylor DR and Hooper NM (2007) The low-density lipoprotein receptor-related protein 1 (LRP1) mediates the endocytosis of the cellular prion protein. Biochem J, 402, 17-23.
204. Telling GC, Haga T, Torchia M, Tremblay P, DeArmond SJ, and Prusiner SB (1996) Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev, 10, 1736-1750.
205. Theodosis DT, Piet R, Poulain DA, and Oliet SH (2004) Neuronal, glial and synaptic remodeling in the adult hypothalamus: functional consequences and role of cell surface and extracellular matrix adhesion molecules. Neurochem Int, 45, 491-501.
206. Theodosis DT, Poulain DA, and Oliet SH (2008) Activity-dependent structural and functional plasticity of astrocyt-eneuron interactions. Physiol Rev, 88, 9831008.
207. Thiel G and Cibelli G (2002) Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol, 193, 287-292.
208. Thoenen H, Hughes RA, and Sendtner M (1993) Trophic support of motoneurons: physiological, pathophysiological, and therapeutic implications. Exp Neurol, 124, 47-55.
209. Tobler I, Deboer T, and Fischer M (1997) Sleep and sleep regulation in normal and prion protein-deficient mice. J Neurosci, 17, 1869-1879.
210. Tobler I, Gaus SE, Deboer T, Achermann P, Fischer M, Rulicke T, Moser M, Oesch B, McBride PA, and Manson JC (1996) Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature, 380, 639-642.
211. Tzu J and Marinkovich MP (2008) Bridging structure with function: structural, regulatory, and developmental role of laminins. Int J Biochem Cell Biol, 40, 199-214.
212. Vana K and Weiss S (2006) A trans-dominant negative 37kDa/67kDa laminin receptor mutant impairs PrP(Sc) propagation in scrapie-infected neuronal cells. J Mol Biol, 358, 57-66.
213. Vella LJ, Greenwood DL, Cappai R, Scheerlinck JP, and Hill AF (2008) Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid. Vet Immunol Immunopathol, 124, 385-393.
214. Vey M, Pilkuhn S, Wille H, Nixon R, DeArmond SJ, Smart EJ, Anderson RG, Taraboulos A, and Prusiner SB (1996) Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci U S A, 93, 14945-14949.
215. Viard P, Butcher AJ, Halet G, Davies A, Nurnberg B, Heblich F, and Dolphin AC (2004) PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane. Nat Neurosci, 7, 939-946.
216. Vincent B, Cisse MA, Sunyach C, Guillot-Sestier MV, and Checler F (2008) Regulation of betaAPP and PrPc cleavage by alpha-secretase: mechanistic and therapeutic perspectives. Curr Alzheimer Res, 5, 202-211.
217. Vincent B, Paitel E, Frobert Y, Lehmann S, Grassi J, and Checler F (2000) Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons. J Biol Chem, 275, 35612-35616.
218. Vincent B, Paitel E, Saftig P, Frobert Y, Hartmann D, De SB, Grassi J, Lopez-Perez E, and Checler F (2001) The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem, 276, 37743-37746.
219. Walz R, Amaral OB, Rockenbach IC, Roesler R, Izquierdo I, Cavalheiro EA, Martins VR, and Brentani RR (1999) Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia, 40, 1679-1682.
220. Warner RG, Hundt C, Weiss S, and Turnbull JE (2002) Identification of the heparan sulfate binding sites in the cellular prion protein. J Biol Chem, 277, 18421-18430.
221. Weise J, Crome O, Sandau R, Schulz-Schaeffer W, Bahr M, and Zerr I (2004) Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity. Neurosci Lett, 372, 146-150.
222. Weise J, Doeppner TR, Muller T, Wrede A, Schulz-Schaeffer W, Zerr I, Witte OW, and Bahr M (2008) Overexpression of cellular prion protein alters postischemic Erk1/2 phosphorylation but not Akt phosphorylation and protects against focal cerebral ischemia. Restor Neurol Neurosci, 26, 57-64.
223. Weise J, Sandau R, Schwarting S, Crome O, Wrede A, Schulz-Schaeffer W, Zerr I, and Bahr M (2006) Deletion of cellular prion protein results in reduced Akt activation, enhanced postischemic caspase-3 activation, and exacerbation of ischemic brain injury. Stroke, 37, 1296-1300.
224. Whatley SA, Powell JF, Politopoulou G, Campbell IC, Brammer MJ, and Percy NS (1995) Regulation of intracellular free calcium levels by the cellular prion protein. Neuroreport, 6, 2333-2337.
225. White AR, Enever P, Tayebi M, Mushens R, Linehan J, Brandner S, Anstee D, Collinge J, and Hawke S (2003) Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature, 422, 80-83.
226. White MD, Farmer M, Mirabile I, Brandner S, Collinge J, and Mallucci GR (2008) Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc Natl Acad Sci U S A, 105,
227. Wiese S, Jablonka S, Holtmann B, Orel N, Rajagopal R, Chao MV, and Sendtner M (2007) Adenosine receptor A2A-R contributes to motoneuron survival by transactivating the tyrosine kinase receptor TrkB. Proc Natl Acad Sci U S A, 104, 17210-17215.
228. Williams GR (2008) Neurodevelopmental and neurophysiological actions of thyroid hormone. J Neuroendocrinol, 20, 784-794.
229. Wong K, Qiu Y, Hyun W, Nixon R, VanCleff J, Sanchez-Salazar J, Prusiner SB, and DeArmond SJ (1996) Decreased receptor-mediated calcium response in prion-infected cells correlates with decreased membrane fluidity and IP3 release. Neurology, 47, 741-750.
230. Yan-Feng W, Gang L, and Yan-Ting G (2008) Bradykinin preconditioning induces protective effects on the spinal cord ischemic injury of rats. Neurosci Lett, 433, 114-118.
231. Yano H and Chao MV (2000) Neurotrophin receptor structure and interactions. Pharm Acta Helv, 74, 253-260.
232. Ye J, Han J, Shi Q, Zhang BY, Wang GR, Tian C, Gao C, Chen JM, Li CJ, Lui Z, Li XZ, Zhang LZ, and Dong XP (2008) A genetic human prion disease with G114V mutation in PRNP and epidemiological studies in a Chinese family: a case series. J Med Case Reports, 2, 331.
233. Zahn R, Liu A, Luhrs T, Riek R, von SC, Lopez GF, Billeter M, Calzolai L, Wider G, and Wuthrich K (2000) NMR solution structure of the human prion protein. Proc Natl Acad Sci U S A, 97, 145-150.
234. Zanata SM, Lopes MH, Mercadante AF, Hajj GN, Chiarini LB, Nomizo R, Freitas AR, Cabral AL, Lee KS, Juliano MA, de Oliveira E, Jachieri SG, Burlingame A, Huang L, Linden R, Brentani RR, and Martins VR (2002) Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J, 21, 3307-3316.
235. Zhang J, Zhang D, McQuade JS, Behbehani M, Tsien JZ, and Xu M (2002) c-fos regulates neuronal excitability and survival. Nat Genet, 30, 416-420.
236. Zuber C, Knackmuss S, Rey C, Reusch U, Rottgen P, Frohlich T, Arnold GJ, Pace C, Mitteregger G, Kretzschmar HA, Little M, and Weiss S (2008) Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseases. Mol Immunol, 45, 144-151.